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Because results from single-center (mostly kidney)
donor studies demonstrate interpersonal relationship
and financial strains for some donors, we conducted a
liver donor study involving nine centers within the
Adult-to-Adult Living Donor Liver Transplantation
Cohort Study 2 (A2ALL-2) consortium. Among other
initiatives, A2ALL-2 examined the nature of these out-
comes following donation. Using validated measures,
donors were prospectively surveyed before donation
and at 3, 6, 12, and 24 mo after donation. Repeated-
measures regression models were used to examine
social relationship and financial outcomes over time
and to identify relevant predictors. Of 297 eligible
donors, 271 (91%) consented and were interviewed at
least once. Relationship changes were positive overall
across postdonation time points, with nearly one-
third reporting improved donor family and spousal or
partner relationships and >50% reporting improved
recipient relationships. The majority of donors, how-
ever, reported cumulative out-of-pocket medical and
nonmedical expenses, which were judged burden-
some by 44% of donors. Lower income predicted bur-
densome donation costs. Those who anticipated
financial concerns and who held nonprofessional posi-
tions before donation were more likely to experience
adverse financial outcomes. These data support the
need for initiatives to reduce financial burden.
Abbreviations: A2ALL-2, Adult-to-Adult Living Donor
Liver Transplantation Cohort Study 2; CI, confidence
interval; IQR, interquartile range; NA, not applicable;
NLDAC, National Living Donor Assistance Center;
OR, odds ratio; PHQ-9, Patient Health Questionnaire
9; SD, standard deviation
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Introduction
The increasing need to consider living liver donation as a
more expeditious and certain alternative to deceased
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donor transplantation necessitates ongoing efforts to
maximize donor well-being. Beyond commonly consid-
ered generic quality of life (often focused on donors’
physical and psychological well-being), the impact of
donation on the larger context of donors’ interpersonal
lives, relationships and need for adequate social and
financial resources before donation has been considered
less often. Social and financial circumstances are impor-
tant interrelated areas, especially given their potential for
reciprocal influence. Donation-related financial strains, for
example, may strain family, spouse or partner, and/or
recipient relationships within a donor’s social support
network. Alternatively, interpersonal relationships may
provide a buffer against financial hardship. These issues
are particularly pertinent to donors who are less finan-
cially or socially prepared to handle such strains.
Although an increasing body of literature from small, ret-
rospectively studied, single-center, mostly kidney donor
cohorts suggests that living donors can experience signif-
icant problems related to interpersonal relationships,
work and finances, it remains largely unknown whether
liver donors are at similar risk (1). To date, the sparse lit-
erature indicates liver donors’ relationships with recipi-
ents or family members can be strained or can worsen
after donation (2–4). Liver donors may experience more
family conflicts related to the decision to donate com-
pared with kidney donors (5) and can encounter burden-
some donation-related expenses (1,4,6,7).
Studies also suggest how donation-related social and
financial outcomes may be mutually affected. Kidney
donors can experience financial stresses that could affect
their family or spousal relationships because of lost work
and wages for both donors and their family caregivers;
decreased home productivity; and costs for dependent
care, transportation and housing (8–10). A single-center
study of liver donors demonstrated the potential financial
impact on donors’ social relationships due to donors
using personal or family savings or retirement funds, ask-
ing family or friends for loans, declaring bankruptcy, or
having a family member get a second job to pay uncov-
ered donation-related medical expenses (7). Insurability is
another financial issue that potentially affects donor rela-
tionships. Prior reports demonstrate that some donors
have difficulties keeping or obtaining health and life insur-
ance (11–13). On the one hand, studies of liver donors
could be expected to reveal more frequent and extensive
issues, given the greater magnitude of their donation sur-
gery compared with kidney donation (5). On the other
hand, the higher risks associated with liver donation sur-
gery and the potential for complications may lead to
more stringent social and financial selection criteria.
These initial studies led to recommendations for further
research (7,12–14) to delineate the scope of these issues
for liver donors. With this intent, we sought to prospec-
tively survey liver donors enrolled in the nine-center Adult-
to-Adult Living Donor Liver Transplantation Cohort Study 2
(A2ALL-2). The prospective repeated-measures design
facilitated the examination of whether social or financial dif-
ficulties arose and persisted during the first 2 years after
donation. Mutually considering donors’ perceptions of
poorer social and financial outcomes allowed identification
of their coincidence and examination of shared predictors.
Methods
Study design and cohort
The A2ALL-2 consortium consists of nine North American transplant cen-
ters. All centers followed the medical and psychosocial evaluation and
exclusion criteria for living liver donor selection now included in current
U.S. national policy (15). Centers began prospective study enrollment
between February and July 2011 and ended enrollment January 31,
2014. Donors were eligible for the present study if they spoke English
and were scheduled for but had not yet undergone liver donation.
Procedure
Potential liver donors were approached by center clinical staff, and
informed consent was obtained by center study coordinators before
scheduled donation. Survey centers for centralized data collection subse-
quently contacted donors to complete 30- to 45-min telephone surveys
before donation (i.e. within 1 mo) and at 3, 6, 12, and 24 mo after dona-
tion. Donors who did not reach an interview time period by the end of
study follow-up on July 15, 2014, were administratively censored at that
time point (29 censored at 1 year and another 66 censored at 2 years
after donation). Participants were offered $20 for each interview com-
pleted. Interviewers used computer-assisted phone interviews for data
collection. This approach ensures that interviewers use consistent word-
ing, eliminates independent data entry and minimizes transcription and
coding errors. After initial training, interviewers were monitored for qual-
ity assurance and underwent periodic retraining.
The study was approved by the institutional review and privacy boards of
the University of Michigan Data Coordinating Center and all participating
centers.
Measures
Social relationship outcomes following donation: We chose key
items related to donors’ perceptions of interpersonal relationship
experiences from donation-specific instruments created and validated
previously (16) and used extensively in kidney, liver and bone marrow
donation research (17–24) (descriptors and item scales are shown in
Table 1).
Financial outcomes following donation: Donors’ experiences of
financial difficulties from health-related expenses and changes in
employment and health or life insurance benefits were obtained using
the Financial Burden of Donation measure (2,3,25,26) (Table 1).
Predictors of social relationship and financial outcomes:
Potential predictors included donor demographics, clinical characteristics,
donor–recipient relationship and whether the donor was aware of recipient
death before each survey (Table 1). We also tested whether early recipient
death (within 3 mo after donation) was associated with outcomes.
Additional predictors included predonation survey items assessing donor
relationship and financial perceptions, expectations and concerns about
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Table 1: Instruments used to assess postdonation relationship and financial domains and their predonation predictors
Measure Instrument and scoring Scoring of instrument or items Source
Postdonation donor family relationships outcomes
Family relationship quality1 Single item asked about change compared to
before donation, rated on a 5-point scale from
“gotten much worse” to “improved greatly”
Improved (scores of ≥4) versus
not
(16)
Family relationship more
difficult1
Single item asked about change compared with
before donation, rated on 10-point scale from
“not at all true” to “very true”
Agree (scores of ≥6) versus not (16)
Family expressed gratitude1 Single item asked about gratitude expressed
since donation, rated on 10-point scale from
“not at all true” to “very true”
Agree (scores of ≥6) versus not (16)
Family holds me in higher
esteem1
Single item asked about being held in higher
esteem by family since donation, rated on
10-point scale from “not at all true” to
“very true”
Agree (scores of ≥6) versus not (16)
Postdonation spouse/partner relationships outcome
Relationship with spouse/
partner changed1
Single item asked about change compared with
before donation, rated on 5-point scale from
“gotten much worse” to “improved greatly”
Improved (scores of ≥4) versus
not
(16)
Postdonation recipient relationships outcomes
Relationship with recipient1 Single item asked about change compared to
before donation, rated on 5-point scale from
“gotten much worse” to “improved greatly”
Improved (scores of ≥4) versus
not
(16)
Donor recipient relationship
quality1
Single item asked about overall quality of the
relationship with the recipient since donation,
rated 5-point scale from “poor” to “excellent”
Very good to excellent (scores of
≥4) versus all other responses
(16)
Feel closer to the recipient1 Single item asked about feeling closer to the
recipient than before donation, rated on 4-point
scale from “strongly disagree” to “strongly
agree”
Agree versus not (16)
Worried about your recipient1 Single item asked about degree of worry, rated
on 4-point scale
Worried versus not (16)
Want more contact with
recipient
Single item asked about contact preferences,
rated as “yes, would like a lot more
communication”; “yes, would like a little more
communication”; or “no, would not like more
communication”
Yes versus no (16)
Interactions with recipient1 Seven items asked about qualities of their
interactions with recipient as positive or
negative on a 7-point semantic differential scale
(e.g. close vs. distant)
Positive interactions (scores of
≥5) versus not
(16)
Postdonation financial outcomes
Cost questions were asked about out of pocket costs not covered by insurance and “Since we last spoke with you. . .”
Donation related costs were a
burden1
Single item about whether costs were significant
financial burden, 4-point scale (1 = no; 2 = yes,
mild burden; 3 = yes, moderate burden;
4 = yes, severe burden)
Yes versus no (2)
Nonreimbursed medical costs Two items asked about whether the donor had
had medical bills and medication costs
Yes (if either endorsed) versus
no
(2,3)
Nonreimbursed non-medical
costs
Five items asked about whether the donor had
had lost wages, family/child care,
transportation/parking, housing, food
Yes (if any endorsed) versus no (2,3)
Costs compared to
expectations1
Single item, rated as “less than expected,”
“more than expected,” or “about as expected”
More than expected versus not (2)
Job and income questions asked “Since we last spoke with you . . . because of your donation”
Change in income due to
donation
Single item Decreased versus not (2)
Changed or modified your job
due to donation
Single item Yes versus no (2)
(Continued )
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Table 1. Continued
Measure Instrument and scoring Scoring of instrument or items Source
Insurance questions were asked “Since we last spoke with you . . . because of the donation”
Had postdonation problems
getting or keeping health
insurance
Two items asked whether donor had trouble
getting or keeping health insurance
Yes versus no (no includes “tried
to get/keep insurance; had no
problems” and “did not try to
get new insurance”)
(26)
Had postdonation problems
getting or keeping life
insurance
Two items asked whether donor had trouble
getting or keeping life insurance
Yes versus no (no includes “tried
to get/keep insurance; had no
problems” and “did not try to
get new insurance”)
(26)
Currently have health
insurance
Single item asking about whether donor had
medical insurance at the time of interview
“Yes, have insurance” versus
“no, do not have insurance”
(26)
Predonation predictor variables
“Black sheep” Two items asked about whether family was
generally approving and accepting of the donor’s
life and if the donor had done anything major
in his or her life of which family did not approve
Family disapproval present versus
not
(16)
Anyone encouraged donor to
donate
Nine items asked about whether the recipient,
family, and extended family or friends had
encouraged donation
Anyone versus no one
encouraged donor
(16)
Anyone discouraged donor to
donate
Nine items asked about whether the recipient,
family, and extended family or friends had
discouraged donation
Anyone versus no one
discouraged donor
(16)
Ambivalence Seven items asked about whether the donor had
lingering feelings of hesitation and uncertainly
about whether to donate, rated on 8-point
scale, higher scores reflect greater ambivalence
Continuous summary score from
0 (no ambivalence) to 7 (highest
ambivalence)
(16)
Positive relationship with
recipient
Three items asked about quality of relationship
with the recipient, rated on 7-point scale from
“not at all accurate” to “very accurate” about
whether the donor felt the recipient saw eye to
eye on most issues, had a warm and close
relationship, and generally enjoyed each other’s
company (excluded those with no relationship
with recipient)
Average of items (16)
Spouse/partner or parents
disagree with donation
decision
Two items asked about whether the donor’s
spouse/partner or parents supported or
disagreed with the donation decision
Yes, disagreed versus not (16)
Patient Health Questionnaire 9,
depression
Nine items asked about severity of symptoms of
depression, each rated on a scale from 0 to 3
Continuous summary score from
0 (no depressive symptoms) to
27 (maximal depressive
symptoms)
(35)
Occupation classification One item asked about predonation occupation Classified as semiprofessional/
professional versus technical/
clerical or lower-level position
based on the Hollingshead
Index of Social Position
(36)
Days donor anticipated being
in hospital
One item asked about how many days the donor
expected to be in the hospital following
donation
Number of days (16)
How long donor thinks he or
she will be off work
One item asked about how many months the
donor expected to be off work, if employed
<1, 1–3 and >3 mo and not
employed
(16)
How long donor thinks it will
take until he or she feels back
to normal
One item asked about how long the donor
expected it would take to feel back to normal
<1, 1–3 and >3 mo (16)
Concerns about missing work One item asked whether donor had concerns
about missing time from work
Yes versus no (16)
Concerns about who would
pay for procedure
One item asked whether donor had concerns
about who would pay
Yes versus no (16)
1These outcomes were dichotomized in the analyses because of their highly skewed distributions and because we were interested in
identifying subgroups of patients with bad (or good) social and financial outcomes and predictors of those subgroups.
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postdonation experiences (16); the Patient Health Questionnaire 9
depression score (Table 1); and predonation household income, employ-
ment status and occupation.
Statistical analysis
Demographics of survey respondents and nonrespondents were com-
pared using t-tests for continuous variables and chi-square or Fisher exact
tests for categorical variables. Among respondents, we similarly com-
pared completers, those who withdrew consent during the study period
(permanent refusers or study dropouts), intermittent refusers (refused
one or more interviews but were willing to be called again) and adminis-
tratively censored donors.
Descriptive statistics were used to examine social and financial outcomes
at each time point. Correlation coefficients were calculated for each pair
of outcomes at 3 mo and 2 years after donation to assess relationships
among outcomes shortly after donation and at longest follow-up, respec-
tively.
Outcomes with 10–90% prevalence at any time point were chosen for
modeling to avoid limited generalizability with sparse outcomes. To inves-
tigate changes in social and financial outcomes and to identify predona-
tion predictors, repeated-measures logistic regression models were fit
among donors who completed the predonation survey and at least one
postdonation survey. Generalized estimating equation models with sand-
wich standard error estimators were used. We started with an unstruc-
tured covariance structure and then simplified to an exchangeable
correlation structure if variances and covariances were homogenous. The
postdonation time point was retained in the models whether or not it
was statistically significant and was used as a categorical variable
because many outcomes did not change linearly over time. Overall tests
across all time points and pairwise tests were conducted to test for sig-
nificant differences in outcomes over time.
Variable selection was guided by the method of best subsets (27).
Final models included predictors that were statistically significant at
the level of p = 0.05. Categorical variables were included if overall
tests were statistically significant or if any pairwise test was statisti-
cally significant after using the Bonferroni correction for multiple com-
parisons (28).
We also examined whether outcomes differed across centers by con-
ducting overall significance tests for center in the final models. To assess
whether adjusting for centers affected the effect sizes of other predic-
tors, we compared the model results before and after controlling for cen-
ters in sensitivity analyses. In financial outcome models, we compared
the Canadian center with all U.S. sites combined because of differences
in health insurance.
Because 12 donors (5%) included in the models were missing predona-
tion income, we also conducted two sets of sensitivity analyses by
replacing all missing incomes with either the lowest or highest income
category.
A prior A2ALL report showed that the majority of donor complications
occur in the first weeks following donation (29). To test whether donor
complications that occurred beyond 1 mo influenced responses at later
time points, we performed sensitivity analyses using complications or
rehospitalization within 3 mo after donation among those who had clinical
data available at 3 mo.
All analyses were performed using SAS version 9.4 (SAS Institute, Inc.,
Cary, NC).
Results
Overall, 91.2% (271 of 297) of eligible donors gave con-
sent and were interviewed at least once during the
study, with 245 interviewed both before and after dona-
tion, 8 before donation only and 18 after donation only
(Figure 1).
Demographics and clinical characteristics of respondents
are presented in Table 2. We compared available demo-
graphics between nonrespondents (n = 26) and respon-
dents (n = 271), and no significant differences were
found (p = 0.74 for gender, p = 0.36 for age and
p = 0.11 for race/ethnicity). Nonrespondents were 54%
female, 69% non-Hispanic white, 15% Hispanic and
16% other race/ethnicity and had a mean age of 34.70
years (standard deviation 9.28 years). Among respon-
dents, there were few differences in demographics and
clinical characteristics of completers, permanent refu-
sers, intermittent refusers and administratively censored
donors (all p-values ≥0.12).
Prevalence of postdonation social relationship
outcomes
At each postdonation time point, 25–34% of donors indi-
cated that their family and spouse or partner (if applica-
ble) relationships improved (Table 3), whereas the
majority (>60%) reported that relationships stayed the
same as before donation. Among donors who had inter-
actions with their recipients before the postdonation
interview (n = 239), a greater proportion (≥54% at every
time point) reported improved recipient relationships.
Less than 3% reported that their relationships with their
recipients got worse at any time point. The vast majority
of donors reported higher quality recipient relationships
after donation (86–93% across time points) and feeling
closer to their recipients (77–84%). More than 90%
reported that their interactions with recipients were
rewarding, comfortable, easy, positive, relaxed, close,
and natural (Table S1).
Nearly 42% of donors reported that they worried about
their recipients at 3 mo after donation, but this proportion
was 25–29% by 1–2 years after donation (Table 3). Simi-
larly, the percentages of donors reporting that their fami-
lies expressed gratitude and held them in higher esteem
were both highest at 3 mo (82% and 54%, respectively)
and were 10% lower at 2 years after donation.
Prevalence of postdonation financial outcomes
Endorsement of donation-related adverse financial out-
comes was highest at 3 mo after donation and lowest at
1 or 2 years after donation (Table 4). Although health
insurance was not required by half of the U.S. centers or
by the Canadian center, >92% of donors reported having
health insurance after donation. Nevertheless, in total,
37% incurred out-of-pocket donation-related medical
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271 donors with at 
least one survey 
(respondents)
278 eligible at 3 months postdonation
- 250 interviewed (90%)
- 28 not interviewed (19 refused this survey, 4 refused permanently at this 
survey, 1 missed due to communication error, 4 not approached for interview 
due to administrative error)
278 eligible at 6 months postdonation
- 241 interviewed (87%)
- 37 not interviewed (21 refused this survey, 4 refused permanently prior to this 
survey, 7 refused permanently at this survey, 1 no longer receiving care from 
A2ALL center, 4 not approached for interview due to administrative error)
278 eligible at predonation
- 253 interviewed (91%)
- 25 not interviewed (9 refused this survey, 11 missed due to surgery timing, 1 
missed due to communication error, 4 not approached for interview due to 
administrative error)
278 actual donors enrolled 
19 did not consent (nonrespondents ) *
- 16 refused to consent
- 3 not approached for consent due to 
administrative error
297 eligible actual donors
18 with only post-
donation surveys 
were analyzed 
descriptively only
245 with both pre- and at least 
one postdonation survey 
were analyzed both 
descriptively and in models
8 with only pre-
donation survey 
were analyzed 
descriptively only
249 eligible at 1 year postdonation
- 201 interviewed (81%)
- 48 not interviewed (18 refused this survey, 12 refused permanently or were 
lost to follow-up prior to this survey, 14 refused permanently at this survey, 1 
lost to follow-up, 3 not approached for interview due to administrative error)
183 eligible at 2 years postdonation
- 139 interviewed (76%)
- 44 not interviewed (15 refused this survey, 27 refused permanently or were 
lost to follow-up prior to this survey, 2 not approached for interview due to 
administrative error)
29 study ended prior to follow-up
66 study ended prior to follow-up 
7 donors with no survey (nonrespondents )
- 4 not approached for interview due to 
administrative error
- 3 refused all interviews
Note: There were 30 potential donors consented to the study but did not donate. These 30 subjects were not included in this 
flow chart.
† The last subject was enrolled January 17, 2014 and the last surgery was performed January 28, 2014 for the same subject.
* The donation statuses for these 19 donor candidates were unknown as they didn’t consent to this study.
Figure 1: Participant flow diagram. This diagram shows the number of eligible actual donors who consented to the study, who
were interviewed by the survey center and who were included in descriptive analyses and models. Donors were eligible at each time
point if they had reached that time point before being administratively censored at the end of study on July 15, 2014.†
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Table 2: Demographic and donation-related characteristics of
respondents (n = 271)
Characteristic
% (n) or
Mean (SD)
Female 57.2% (155)
Age at donation (years) 36.79 (10.51)
Race/ethnicity
Non-Hispanic white 80.4% (218)
Hispanic 9.2% (25)
Native American or Alaskan Native 1.8% (5)
Asian 3.0% (8)
Black or African American 2.6% (7)
Native Hawaiian or other Pacific Islander 2.6% (7)
Other 0.4% (1)
Education at survey
High school or less 17.3% (47)
Vocational or some college 29.2% (79)
College graduate 28.8% (78)
Postgraduate 18.1% (49)
Unknown 6.6% (18)
Married or long-term partner 63.1% (171)
Relation to transplant recipient
First-degree relative 53.1% (144)
Parent 2.2% (6)
Child 36.2% (98)
Sibling 14.8% (40)
Spouse/partner 6.3% (17)
Other biological or nonbiological relative 19.2% (52)
Unrelated5 21.4% (58)
BMI at donation (kg/m2)
<18.5 1.1% (3)
18.5–24.9 35.4% (96)
25.0–29.9 46.5% (126)
≥30 17.0% (46)
Postdonation length of hospital stay (days) 5.50 (1.99)
Range 1–24
Donating right lobe versus left lobe or left
lateral segment
84.1% (228)
Number of postoperative complications during the first month
after donation1
0 80.4% (218)
≥1 19.2% (52)
Number of rehospitalizations during the first month after
donation1
0 91.5% (248)
≥1 7.7% (21)
Postdonation recipient vital status from donor-reported survey
data (n = 263)
Donor ever aware of recipient death3 10.3% (27)
How long after donation surgery did the recipient die
0–2.9 mo 5.7% (15)
3–5.9 mo 2.3% (6)
6–11.9 mo 1.5% (4)
12–24 mo 0.8% (2)
Weeks after donation that recipient death
occurred (n = 27)
16.11 (18.22)
Predonation predictors from survey data (n = 253)
“Black sheep” donor 28.5% (72)
Anyone encouraged donor to donate4 13.4% (34)
Anyone discouraged donor to donate4 46.6% (118)
(Continued )
Table 2. Continued
Characteristic
% (n) or
Mean (SD)
Ambivalence scale (0 = no ambivalence;
7 = highest ambivalence)
1.97 (1.58)
Positive relationship with recipient (1 = not
at all accurate; 7 = very accurate) (n = 240)
6.03 (0.97)
Spouse/partner or parents disagree with
donor’s decision to donate
7.5% (19)
PHQ-9 depression score (0 = no depressive
symptoms; 27 = maximal symptoms)
1.45 (2.30)
Range 0–16
Employed1
Full time 65.1% (164)
Part time 15.9% (40)
Unemployed or retired 19.0% (48)
Household income2
≤$40 000 22.8% (55)
$40 001–80 000 27.4% (66)
$80 001–120 000 26.1% (63)
>$120 000 23.7% (57)
Household size, mean (SD) 3.28 (1.54)
Median (IQR) 3 (2–4)
Hollingshead categories
Semiprofessional/professional 56.1% (142)
Technical/clerical or lower-level position 43.9% (111)
Days donor expects to be in hospital after
donation
5.77 (1.43)
How long donor expects to be off work1
<1 mo 26.1% (66)
1–3 mo 35.6% (90)
>3 mo 21.0% (53)
Not employed 16.6% (42)
How long donor thinks it will be until he or she feels back to
normal1
<1 mo 9.5% (24)
1–3 mo 77.9% (197)
>3 mo 11.9% (30)
Concerns about missing work 39.5% (100)
Concerns about who would pay donation
costs
13.0% (33)
Variables had no missing data except as noted. IQR, interquartile
range; PHQ-9, Patient Health Questionnaire 9; SD, standard
deviation.
1Missing < 1%.
2Missing = 5% (n = 12).
3Five donors reported that they did not know recipient vital sta-
tus during at least one time point.
4Among 34 donors who were encouraged to donate, 27 (79%)
were encouraged by first-degree relatives, 16 (47%) by spouses
or partners, 14 (41%) by other relatives, and 22 (65%) by unre-
lated people. Among 118 donors who were discouraged, 55
(47%) were discouraged by first-degree relatives, 21 (18%) by
spouses or partners, 27 (23%) by other relatives, and 70 (59%)
by unrelated people. In addition, 22 (65% of 34) were encour-
aged and 38 (32% of 118) were discouraged by more than one
type of relationship.
5Nine donors were anonymous in this unrelated donor–recipient
relationship group.
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expenses not covered by insurance including medical bills
and medication costs. Some donors continued to experi-
ence medical expenses as long as 1 and 2 years after
donation (12.4% and 9.4%, respectively). Cumulatively,
75% of donors reported some nonmedical out-of-pocket
expenses (i.e. 45% lost wages, 60% transportation, 27%
housing, 41% food expenses, and 7% child or family care
costs) (Table S2). The proportions of donors who reported
that donation-related costs were a burden were 40% at
3 mo and 19% at 2 years after donation; cumulatively,
44% reported this burden. Almost 12–16% of donors,
24% cumulatively, reported that donation costs were
more than expected, and percentages were similar over
the follow-up period.
Among donors employed at least part time before dona-
tion (n = 196), 34% reported changing jobs or modifying
work because of donation at 3 mo after donation, but
only 1% reported doing so at 2 years; cumulatively, 40%
reported such a change. Although cumulatively 7% chan-
ged to jobs with less manual labor, the majority of
donors who noted other changes—30% total across all
time points—reported changes due to reduced working
hours. The proportions reporting decreased income due
to donation were 41% at 3 mo and 1% at 2 years.
Difficulties getting or keeping health or life insurance ran-
ged from 1% to 4% across all time points. Cumulatively,
5% reported difficulties with health insurance and 3%
with life insurance. Across the time points, 2–7% (12%
cumulatively) reported no current health insurance.
Although Canadian donors have access to governmental
health insurance, which covers medical services, they
may also have additional insurance through an employer
or purchase private insurance to pay for costs not cov-
ered by their universal health care, such as prescription
medications (separate U.S. and Canadian data are shown
in Table S3).
Correlations between social and financial outcomes
The financial outcomes were significantly correlated with
each other at 3 mo after donation (rφ between 0.23 and
0.41) (Table 5) but had little intercorrelation at 2 years.
Several social relationship outcomes were significantly
Table 3: Social relationship outcomes over time
Outcome
3 mo after
donation
(n = 250)
6 mo after
donation
(n = 241)
1 year after
donation
(n = 201)
2 years after
donation
(n = 139)
All donors (n = 263; 100%)
Family relationship quality1
Improved 33.2% (83) 31.3% (75) 29.9% (60) 25.9% (36)
Stayed the same 63.2% (158) 66.3% (159) 64.2% (129) 71.9% (100)
Got worse 3.6% (9) 2.5% (6) 6.0% (12) 2.2% (3)
Family expressed gratitude, % agree2 82.4% (206) 82.0% (196) 77.1% (155) 74.6% (103)
Family holds me in higher esteem, % agree3 54.4% (136) 53.3% (128) 48.8% (98) 44.9% (62)
Family relationship more difficult, % agree4 7.2% (18) 4.6% (11) 7.0% (14) 7.2% (10)
Donors who are married or live with a long-term
partner and spouse/partner is not the recipient (n = 162; 61.6%)
n = 148 n = 132 n = 106 n = 74
Relationship with spouse/partner, quality1
Improved 33.8% (50) 29.0% (38) 29.2% (31) 33.8% (25)
Stayed the same 61.5% (91) 62.6% (82) 65.1% (69) 62.2% (46)
Got worse 4.7% (7) 8.4% (11) 5.7% (6) 4.1% (3)
Donors whose recipients are alive and donor had interactions
with their recipients (n = 239; 90.9%)1,5
n = 229 n = 213 n = 181 n = 120
Relationship with recipient, quality
Improved 53.7% (123) 56.8% (121) 54.1% (98) 55.8% (67)
Stayed the same 43.7% (100) 40.4% (86) 43.1% (78) 42.5% (51)
Got worse 2.6% (6) 2.8% (6) 2.8% (5) 1.7% (2)
Donor recipient relationship quality, % very good to excellent 92.6% (212) 88.3% (188) 86.2% (156) 88.3% (106)
Closer to recipient, % agree 84.3% (193) 78.9% (168) 77.3% (140) 84.2% (101)
Donors whose recipients are alive (n = 247; 93.9%) n = 234 n = 220 n = 184 n = 122
Worried about recipient, % worried 41.9% (98) 35.5% (78) 25.0% (46) 28.7% (35)
Want more contact, % yes4 33.8% (79) 32.4% (71) 31.1% (57) 32.8% (40)
Data are shown as % (n) or mean (standard deviation). Sensitivity analyses among only donors who completed all surveys (n = 119)
showed results similar to those who completed at least one postdonation survey (n = 263).
1n = 1 missing at 6 mo.
2n = 2 missing at 6 mo and n = 1 missing at 2 years.
3n = 1 missing at 6 mo and n = 1 missing at 2 years.
4n = 1 missing at 6 mo and n = 1 missing at 1 year.
5Donors whose recipients died or who were not aware of recipient vital status or donors who had no interactions with their recipients
responded “not applicable” to these recipient relationship questions.
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correlated with each other at both 3 mo and 2 years after
donation. Improved relationships were intercorrelated
among all relationship outcomes for family, spousal or
partner, and recipient relationships (rφ between 0.21 and
0.56). Donors who reported improved family, spousal or
recipient relationships were also more likely to report that
their families held them in higher esteem (rφ between 0.16
and 0.39). Those whose families expressed gratitude were
also more likely to report that their families held them in
higher esteem (rφ = 0.38 at 3 mo and rφ = 0.49 at 2 years).
Nevertheless, there was little correlation between financial
and relationship outcomes at 3 mo or 2 years.
Predictors of social relationship outcomes
Table 6 shows results from repeated-measures regres-
sion models for social relationship outcomes. The only
outcome that showed significant differences across time
was whether donors were worried about recipients
(overall p < 0.001), which was double the odds at 3 mo
compared with 2 years (p = 0.002).
We modeled improved donor family, spousal and recipi-
ent relationships (vs. no improvement) because the
percentages of donors expressing poorer relationships
were too small for modeling. Donors who were encour-
aged by someone to donate were more likely to report
improved family relationships, and older donor age was
associated with an improved recipient relationship. There
were no significant predictors of improved spousal rela-
tionship. For each outcome, when donors whose rela-
tionship worsened were excluded, the results were
unchanged; therefore, these results are driven mainly by
the comparison of donors whose relationships improved
and those whose relationships stayed the same.
Donors donating to first-degree relatives or to their
spouses or partners were more worried about their recip-
ients compared with those donating to unrelated recipi-
ents (Table 6). Female gender, BMI ≤30, predonation
ambivalence about donation and positive recipient rela-
tionship were also associated with higher odds of being
worried. Donors donating to first-degree or other rela-
tives were more likely to report being held in higher
esteem and having gratitude expressed by their families,
whereas donors whose recipients died were less likely
to report such outcomes. An additional predictor of
Table 4: Financial outcome characteristics over time
Outcome
3 mo after
donation
(n = 250)
6 mo after
donation
(n = 241)
1 year after
donation
(n = 201)
2 years after
donation
(n = 139)
Donation costs were a burden1 39.6% (99) 28.4% (67) 25.4% (51) 19.4% (27)
Incurred medical costs related to donation1,2 26.4% (66) 16.5% (39) 12.4% (25) 9.4% (13)
Incurred nonmedical costs related to donation1 73.2% (183) 36.9% (87) 20.4% (41) 13.7% (19)
Costs compared with expectations3
Less than expected 8.1% (20) 13.2% (31) 11.0% (22) 14.4% (20)
About what was expected 75.7% (187) 71.8% (168) 77.5% (155) 73.4% (102)
More than expected 16.2% (40) 15.0% (35) 11.5% (23) 12.2% (17)
Changed jobs or modified work due to donation4,5 34.2% (63) 12.6% (22) 2.1% (3) 1.0% (1)
Personal income affected by donation5,6
Decreased 41.1% (76) 8.4% (15) 4.1% (6) 1.0% (1)
No change 58.4% (108) 87.7% (157) 92.5% (135) 98.1% (101)
Increased 0.5% (1) 3.9% (7) 3.4% (5) 1.0% (1)
Problems getting or keeping health insurance7,8 2.4% (6) 2.1% (5) 1.0% (2) 3.6% (5)
Problems getting or keeping life insurance7,8 1.2% (3) 0.8% (2) 1.0% (2) 1.4% (2)
Currently have no health insurance6 7.2% (18) 6.3% (15) 6.5% (13) 2.2% (3)
Data are shown as % (n). Sensitivity analyses among only donors who completed all surveys (n = 119) showed results similar to
those who completed at least one postdonation survey (n = 263).
1n = 5 missing at 6 months.
2In the United States, the donation surgery is paid for primarily by the recipient’s insurance, although the donor’s insurance may be
charged for some portion. In Canada, the governmental insurance pays for the donation surgery.
3n = 3 missing at 3 mo, n = 7 missing at 6 mo, and n = 1 missing at 1 year.
4n = 1 missing at 3 mo, n = 8 missing at 6 mo, and n = 4 missing at 1 year.
5Applicable to 196 donors who were employed at least part time before donation (n = 185 at 3 mo, n = 182 at 6 mo, n = 146 at
1 year, and n = 103 at 2 years after donation).
6n = 3 missing at 6 mo.
7Although all Canadian donors are provided with health insurance, Canadian donors were also included in these percentages along
with all other (U.S.) donors in the cohort. Donors who did not have health or life insurance and did not try to get new health or life
insurance were counted as having no problems (17, 14, 12, and 2 donors for health insurance and 71, 68, 62, and 41 donors for life
insurance at 3 mo, 6 mo, 1 year, and 2 years after donation).
8n = 4 missing at 6 mo.
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family-expressed gratitude was whether anyone had
encouraged them to donate.
Early versus late recipient death and predonation financial
predictors were not significant in any models.
Predictors of poor financial outcomes
Model results for postdonation financial outcomes are
presented in Table 7. Each financial outcome was signifi-
cantly different across time (overall p < 0.001 for each
outcome). The odds of costs being a burden at 3 mo
were almost three times the odds at 2 years (p < 0.001),
and the odds at 6 mo were 1.75 times the odds at
2 years (p = 0.01). Similarly, the odds of decreased
income or of job changes or modifications due to dona-
tion were large and statistically significantly different at 3
and 6 mo compared with 2 years (Table 4).
Donors with longer hospital stay and those who, before
donation, anticipated being off work for >3 mo were
more likely to report that postdonation costs were bur-
densome and that their incomes decreased due to dona-
tion. Expected time off work was also associated with
donors reporting that they changed or modified jobs due
to donation; however, donors expecting time off work
for 1–3 mo, compared with <1 or >3 mo, were the least
likely to change or modify jobs.
Additional predictors associated with higher odds of
adverse financial outcomes were predonation concerns
about who would pay donation costs; concern about
missing work, having lower household income, or having
a technical or clerical or lower-level position compared
with a semiprofessional or professional position; and a
lower level of ambivalence about donating.
Table 7: Predictors of financial outcomes from repeated-measures logistic regression models
Predictors1
Costs were a burden
(n = 245)
Decreased income due to
donation2 (n = 196)
Changed or modified jobs
due to donation2,3 (n = 196)
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Postdonation time point4 <0.001 <0.001 <0.001
3 mo versus 2 years 2.96 (1.96–4.47) <0.001 86.23 (12.82–580.17) <0.001 57.94 (6.83–491.42) <0.001
6 mo versus 2 years 1.75 (1.12–2.72) 0.01 7.87 (1.05–58.96) 0.01 16.07 (1.87–138.29) <0.001
1 versus 2 years 1.33 (0.87–2.04) 0.18 3.23 (0.38–27.14) 0.21 2.30 (0.22–24.36) 0.43
Length of hospital stay (per day) 1.22 (1.02–1.45) 0.02 1.54 (1.24–1.91) <0.001
Predonation predictors
Time you think you will be off work 0.02 0.02 0.004
1–3 versus <1 mo (and not
employed2)
1.24 (0.69–2.22) 0.46 1.13 (0.50–2.56) 0.76 0.56 (0.30–1.07) 0.09
>3 versus <1 mo (and not
employed2)
2.77 (1.45–5.31) 0.004 2.85 (1.24–6.56) 0.02 1.76 (0.88–3.49) 0.13
Concern about who will pay donation
costs
3.00 (1.53–5.86) 0.007
Concern about missing work 3.05 (1.62–5.73) <0.001
Household income (per $10 000
increase)
0.93 (0.87–0.98) 0.009
Hollingshead scale semiprofessional/
professional versus technical/clerical
or lower-level position
0.53 (0.29–0.97) 0.046 0.51 (0.29–0.88) 0.02
Ambivalence to donate (1-unit
increase on scale of 0 [no
ambivalence] to 7 [highest
ambivalence])
0.75 (0.62–0.91) 0.008
CI, confidence interval; OR, odds ratio.
1Variables tested but not significant: donor age at donation, sex, race/ethnicity, marital status, education, BMI (obese vs. not obese),
hospitalized within first month after donation, donation complications within first month, donor recipient relationship, donor employment
status, recipient death (time dependent), how long donor thinks he or she will be in hospital (days), how long donor thinks it will take
until he or she feels back to normal, “black sheep” donor, anyone discouraged or encouraged donor to donate, positive relationship
with recipient, spouse/partner or parent disagreement with donation decision, and Patient Health Questionnaire 9 depression score.
2Donors who were not employed before donation were excluded from modeling of decreased income and changed/modified jobs due
to donation.
3Household income was also found to be significant for predicting jobs changes or modifications (OR 0.94 for every $10 000 increase
in income; 95% CI 0.88–1.00); however, it was collinear with Hollingshead categories and thus was not included in Table 7.
4For the pairwise tests, 2 years after donation was chosen as the reference group because we expected donor outcomes at this time
point to be closest to the predonation levels.
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Model results that assessed complications and rehospi-
talizations within 3 mo after donation rather than at 1 mo
remained largely the same for all study outcomes, with
the same direction and similar effects sizes. The sensitiv-
ity analyses evaluating the impact of missing incomes
(n = 12, 5%) showed that all results were unchanged
when all missing incomes were replaced with either the
lowest or highest income category.
Results were also unchanged when controlling for trans-
plant centers, and the center effect was not significant in
any social or financial model. The Canadian center was
not significant in any financial models, and other covari-
ate effects were similar.
Discussion
Our large multisite study of 271 prospectively surveyed
living liver donors establishes the scope and persistence
of relationship changes and financial issues following
donation. Notably, in contrast to some single-center stud-
ies of kidney and liver donors that identified worsening
of family, spouse or recipient relationships for up to 10–
20% (4,14,30), only a small minority (2–8%) of our
donors reported such worsening relationships at any
time point. More important, in comparison to family or
spouse relationships that stayed the same for the major-
ity of donors, more than half reported improved recipient
relationships, and these changes did not diminish over
the 2-year follow-up period. This is similar to a cross-
sectional single-center report with 51% of donors report-
ing improved recipient relationships following donation
(2). Even larger percentages (77–93%) reported closer
and higher quality relationships with their recipients.
Older donors were more likely to experience positive
relationship changes with their recipients, perhaps
reflecting greater maturity or longer term relationships.
Positive relationship experiences, such as being held in
higher esteem or feeling gratitude from the family, were
not sustained over time and decreased by 6 mo after
donation, suggesting that donors may experience less
positive affirmation over time. More worrisome were the
findings that donors whose recipients died were less
likely to report experiencing being held in higher esteem
or gratitude from their families; perhaps as the families
grieved, the generosity and sacrifice of the donor lost
prominence or families were less capable of expressing
such feelings in their grief. Although transplant programs
are typically attentive to the emotional well-being of
donors who have lost their recipients, paying additional
attention to the family dynamics may guide the care of
donors at this vulnerable time. Although a donor’s own
recovery is typically the focus of their postdonation clini-
cal visits, inquiring about how their recipient is recovering
may identify specific concerns, particularly for female
and ambivalent donors, that can be addressed in postdo-
nation counseling.
Whereas donors perceived positive experiences in their
relationships related to donation, nearly half reported expe-
riencing negative financial outcomes (e.g. burdensome
costs, medical expenses, lost wages). Although we
believed poorer relationship and financial outcomes might
coincide, few reported worsening relationships. We also
did not find the converse, that perceived relationship
improvements were associated with less financial stress.
Although removing financial disincentives is widely sup-
ported, donation should be at least “cost neutral” (31) so
that the most financially vulnerable are not exploited or
excluded from donation. Rather than being cost neutral,
we found that the majority of donors reported some out-
of-pocket expenses. For 44% of donors, these costs
were a significant financial burden during at least one
assessment point despite the relatively high average
household income of our donors. Not surprisingly, those
with lower household income were at higher risk for
poorer financial outcomes. Many donors were con-
cerned, even before donating, about missing work (40%)
and about who would pay for the procedure (13%), and
21% anticipated being off work for >3 mo. These donors
were subsequently more likely to experience poorer
financial outcomes, suggesting that they accurately antic-
ipated postdonation financial stresses before donation.
Conversely, donors who expected to be off work <1 mo
were also more likely to experience financial issues, per-
haps related to the unrealistic expectations of their
return-to-work time frame. The association of length of
hospital stay with burdensome costs and decreased
income further demonstrates the uncertainty of predict-
ing future costs related to donation. Donors in nonprofes-
sional positions were also more likely to change or
modify jobs, perhaps representing the greater physical
demands of those positions. Consequently, those who
were most financially vulnerable were most likely to
experience poor financial outcomes.
In an earlier survey, a substantial number of transplant
centers reported having donors decline donation because
of concerns about lack of health insurance (13). Although
most of our donors were insured, 37% reported dona-
tion-related medical expenses that were not covered by
insurance. In January 2014, the Patient Protection and
Affordable Care Act mandated health care coverage for
all U.S. residents and made discrimination in the provi-
sion of health insurance based on preexisting conditions
illegal (32), potentially eliminating some insurance barri-
ers. Nevertheless, complete coverage for all donation
services (e.g. no copays or deductibles) still must be
addressed. That 10% of our donors were still incurring
medical expenses at 1 and 2 years after donation high-
lights that time-limited recipient insurance coverage after
donation is inadequate. A prior study of Canadian donors
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found that 39% had medical expenses that were not
covered by their governmental insurance (2). In addition,
an earlier study using hypothetical liver donor cases
found on telephone inquiries that life insurance compa-
nies were 50% less likely to offer premium rates to
donors compared with other persons or were unwilling
to underwrite donors (11).
We recognize several study limitations. A longer follow-
up period might have identified higher rates of health
and life insurance problems, as were discovered in a
study of kidney donors with mean follow-up of 8–9 years
(32). In our sample, financial outcomes were self-
reported and were not verified with actual costs, out-of-
pocket expenses, income changes or job modifications.
We did not ask specifically about predonation costs
related to the evaluation, which have been demonstrated
to be significant (9). The prospective nature of the study
allows examination of social relationship and financial
changes following donation; however, given our naturalis-
tic design, we cannot know that those factors caused
changes in the outcome. Too few donors reported wors-
ened relationships to explore predictors of these out-
comes. Half of enrolled donors did not have 2-year data.
Most did not reach that time point by study end and
were administratively censored, implying missingness
completely at random. Although some refused the sur-
vey, the similar findings from sensitivity analyses only
among completers indicate that selection biases are
likely minimal. We also noted high participant retention
throughout the study.
Future Directions
Gill et al found that the rate of kidney donation declined
in the past 5 years specifically in the three lowest quin-
tiles of U.S. incomes (33), reflecting the economic reces-
sion. In the two lowest quintiles, spousal donation also
declined, perhaps reflecting the economic strain on
households (33). Because financial resources may influ-
ence decision to donate, financial initiatives will need to
include coverage of expenses beyond donation-related
medical costs (31). National Living Donor Assistance
Center (NLDAC) support is limited to travel and subsis-
tence expenses and is subject to U.S. poverty definitions
for donor and recipient household incomes. Transplant
programs should emphasize the duration of recovery so
donors have a realistic appreciation of potential donation-
related costs. Donors may require more assistance with
fundraising or other strategies to obtain predonation
financial support. Donors should be prepared for unex-
pected financial burdens that can strain finances, particu-
larly for those who travel greater distances to the
transplant program and those with lower household
incomes who may also miss work (10). Pilot projects to
educate donors, to remove disincentives and possibly to
expand resources such as NLDAC are suggested as
important first steps (34). Projects targeting those who
are most financially vulnerable are needed.
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